While Merck’s share prices soared 9% in the wake of the drug’s effects being announced, rival pharma companies’ tumbled
Question marks remain however over the safety of the HPV vaccine Gardasil, with the 49 victims of the vaccine awarded $5,877,710 dollars by the National Vaccine Injury Compensation Program.